Market Place
Sourcing Support
CuraTeQ Bio Enters Into Agreement with Stada Arzneimittel AG
27 Mar 2026 //
INDPHARMAPOST
Aurobindo Pharma’s Generics Cefixime Receives Approval in US
23 Mar 2026 //
FDA
Aurobindo’s Generics Clindamycin Receives Approval in US
18 Mar 2026 //
FDA
APL Healthcare`s Unit-IV Classified As VAI By The USFDA
14 Mar 2026 //
INDPHARMAPOST
Aurobindo Pharma’s Generics Citalopram Receives Approval in US
13 Mar 2026 //
FDA
Aurobindo Pharma’s Generics Siponimod Receives Approval in US
06 Mar 2026 //
FDA
Aurobindo Pharma’s Generics Sitagliptin Receives Approval in US
24 Feb 2026 //
FDA
Aurobindo Pharma To Increase Pen-G Production Capacity To 10K MT
22 Feb 2026 //
BUSINESS STD
FDA Issues Form 483 to Aurobindo Pharma Limited, Unit VII
20 Feb 2026 //
FDA
Aurobindo Pharma’s Generics Aripiprazole Receives Approval in US
18 Feb 2026 //
FDA
Aurobindo Pharma’s Generics Migalastat Receives Approval in US
10 Feb 2026 //
FDA
Aurobindo’s Generics Solriamfetol Receives Tent. Approval in US
04 Feb 2026 //
FDA
Aurobindo’s Generics Betamethasone Receives Approval in US
26 Jan 2026 //
FDA
Aurobindo’s Generics Bisoprolol Fumarate Receives Approval in US
21 Jan 2026 //
FDA
Aurobindo Pharma`s Dyrupeg Faces Health Canada Compliance Notice
09 Jan 2026 //
ECONOMICTIMES
Aurobindo’s Generics Phenylbutyrate Receives Approval in US
07 Jan 2026 //
FDA
Aurobindo’s Receives Generic Approval for Pseudoephrdrine in US
29 Dec 2025 //
FDA
Aurobindo Arm To Acquire Additional 20% Stake In JV Firm
23 Dec 2025 //
ECONOMICTIMES
FDA Issues Form 483 with 5 Observations to Aurobindo Unit
18 Dec 2025 //
ECONOMICTIMES
Aurobindo Pharma’s Generics Cariprazine Receives Approval in US
16 Dec 2025 //
FDA
Aurobindo’s Generics Dapagliflozin Receives Approval in US
10 Dec 2025 //
FDA
Aurobindo Pharma Aims To Break Even At China Plant By Q4 Despite
23 Nov 2025 //
ECONOMICTIMES
Aurobindo`s Generics Potassium Chloride Receives Approval in US
20 Nov 2025 //
FDA
Aurobindo Pharma Receives 9 Observations From USFDA For Eugia
15 Nov 2025 //
INDPHARMAPOST
Aurobindo Pharma’s Generics Fosfomycin Receives Approval in US
14 Nov 2025 //
FDA
Aurobindo Pharma’s Generics Linagliptin Receives Approval in US
03 Nov 2025 //
FDA
Aurobindo Pharma Promoters Raise $2B For Realty And Asset
14 Oct 2025 //
ECONOMICTIMES
FDA Issues Form 483 to Aurobindo Pharma
03 Oct 2025 //
FDA
Aurobindo Pharma’s Generics Naproxen Receives Approval in US
03 Oct 2025 //
FDA
Fire at Subsidiary Temporarily Impact Aurobindo Pharma Production
19 Sep 2025 //
ECONOMICTIMES
CuraTeQ Bio Completes Ph 3 Study for Denosumab Biosimilar
19 Sep 2025 //
INDPHARMAPOST
Aurobindo’s Generics Deferasirox Receives Approval in US
08 Sep 2025 //
FDA
Aurobindo’s Generics Prochlorperazine Receives Approval in US
08 Sep 2025 //
FDA
FDA Issues Form 483 to Aurobindo Pharmaceuticals
05 Sep 2025 //
FDA
Apitoria Pharma Gets 5 Observations from USFDA for API Plant
31 Aug 2025 //
INDPHARMAPOST
Aurobindo`s Unit Receive UK Approval for Biosimilar Breast Cancer
27 Aug 2025 //
BUSINESS STD
Aurobindo Pharma Nears $5.5b Zentiva Acquisition
20 Aug 2025 //
ECONOMICTIMES
Aurobindo Pharma Predicts China Plant EBITDA Break Even This Year
17 Aug 2025 //
ECONOMICTIMES
Aurobindo Pharma`s Generics Pirfenidone Receives Approval in US
11 Aug 2025 //
FDA
Aurobindo Pharma Q1 FY26 PAT Drops 10% YoY to Rs. 824 Cr
10 Aug 2025 //
INDPHARMAPOST
Aurobindo Pharma`s Q1 Pat Drops 10% Due to Lower API Sales
05 Aug 2025 //
BUSINESS STD
Aurobindo to Acquire Lannett Company for Rs. 2,185 Cr
01 Aug 2025 //
INDPHARMAPOST
Aurobindo to Produce, Supply Long Acting HIV Treatment Drug
15 Jul 2025 //
ECONOMICTIMES
Aurobindo’s Generics Ibuprofen and Famotidine Approved in US
30 Jun 2025 //
FDA
Aurobindo Pharma recalls 4,608 pain reliever bottles in US
27 Jun 2025 //
ECONOMICTIMES
Enforcement Report - Week of June 25, 2025
25 Jun 2025 //
FDA
Aurobindo Pharma Q4 PAT falls Marginally to Rs. 903 Cr
27 May 2025 //
INDPHARMAPOST
Aurobindo arm’s Biosimilar Gets Marketing Nod From U.K.’s MHRA
14 May 2025 //
THEHINDU
Aurobindo arm gets USFDA nod for generic blood cancer drug
24 Apr 2025 //
ECONOMICTIMES
Aurobindo`s Generics Esomeprazole Receives Approval in US
15 Apr 2025 //
FDA
Aurobindo gets final approval for Rivaroxaban Tablets
15 Apr 2025 //
INDPHARMAPOST
USFDA issues Form 483 with 11 observations to Aurobindo Pharma
11 Apr 2025 //
ECONOMICTIMES
Aurobindo Pharma acquires 80% stake in Tergene Biotech
01 Mar 2025 //
BUSINESS STD
Aurobindo Pharma Ltd eases for fifth straight session
24 Feb 2025 //
BUSINESS STD
USFDA Inspects Aurobindo Pharma`s Warehouse in New Jersey
20 Feb 2025 //
BUSINESS STD
Aurobindo Pharma Ltd Falls 6.07%, BSE Healthcare index Drops 2.12%
19 Feb 2025 //
BUSINESS STD
Aurobindo Pharma Slips as Andhra Plant Gets 5 USFDA Observations
19 Feb 2025 //
BUSINESS STD
Aurobindo Pharma to supplies to Europe from China plant in April
17 Feb 2025 //
ECONOMICTIMES
Aurobindo To Begin EU Supplies From China Plant In April
16 Feb 2025 //
ECONOMICTIMES
Aurobindo approves acquisition of 80% stake in Tergene Biotech
08 Feb 2025 //
BUSINESS STD
